ANDA 76139, held by Teva. Fosinopril Sodium.
As of Nov 16, 2026, ANDA 76139 (Fosinopril Sodium), held by Teva, was first approved by FDA on Nov 25, 2003, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 25, 2003 | Original application | Approved |
| Fosinopril Sodium10MG · tablet;oral | Fosinopril Sodium | Rx |
| Fosinopril Sodium20MG · tablet;oral | Fosinopril Sodium | Rx |
| Fosinopril Sodium40MG · tablet;oral | Fosinopril Sodium | Rx |
| Sep 29, 2009 | Supplement 5Labeling | Approved | None posted |
| May 8, 2007 | Supplement 3Labeling | Approved | None posted |
| Nov 25, 2003 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters